Literature DB >> 29785583

The effect of delayed anti-NMDAR encephalitis recognition on disease outcome.

Vlatko Sulentic1, Zeljka Petelin Gadze1, Filip Derke2, Marija Santini3, Danira Bazadona1, Sibila Nankovic1.   

Abstract

Anti-NMDA receptor encephalitis is an acute form of brain inflammation that is potentially lethal but has a high probability for recovery with treatment. Although the clinical picture of anti-NMDAR encephalitis is usually recognizable due to its relatively well-known symptoms, the disorder can sometimes present itself in an unpredictable and atypical way. In this case report, we wish to present the influence of different delay times prior to the establishment of diagnosis. Thus, our first patient was diagnosed with anti-NMDAR encephalitis 4 years after the initial symptoms, the second one after 8 years, and the third one after 13 months. The outcomes of the three presented patients indicate the importance of being aware of many clinical presentations of this disorder, as its early diagnosis greatly affects the outcome and may reduce permanent damage, especially in cognitive functions.

Entities:  

Keywords:  Anti-NMDAR encephalitis; Autoimmune encephalitis; Cognitive disorders; Treatment outcome

Mesh:

Year:  2018        PMID: 29785583     DOI: 10.1007/s13365-018-0648-y

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  17 in total

1.  Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review.

Authors:  Gemma L McKeon; Gail A Robinson; Alexander E Ryan; Stefan Blum; David Gillis; Carsten Finke; James G Scott
Journal:  J Clin Exp Neuropsychol       Date:  2017-06-06       Impact factor: 2.475

2.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

3.  Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis.

Authors:  Helen Barry; Orla Hardiman; Daniel G Healy; Mary Keogan; Joan Moroney; Peter P Molnar; David R Cotter; Kieran C Murphy
Journal:  Br J Psychiatry       Date:  2011-10-07       Impact factor: 9.319

4.  Analysis of relapses in anti-NMDAR encephalitis.

Authors:  I Gabilondo; A Saiz; L Galán; V González; R Jadraque; L Sabater; A Sans; A Sempere; A Vela; F Villalobos; M Viñals; P Villoslada; F Graus
Journal:  Neurology       Date:  2011-08-24       Impact factor: 9.910

5.  Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study.

Authors:  Raoul Sutter; Stephan Marsch; Peter Fuhr; Stephan Rüegg
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

Review 6.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

7.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

Review 8.  Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment.

Authors:  Helen Barry; Susan Byrne; Elizabeth Barrett; Kieran C Murphy; David R Cotter
Journal:  BJPsych Bull       Date:  2015-02

9.  Neuroleptic intolerance in patients with anti-NMDAR encephalitis.

Authors:  Florian Lejuste; Laure Thomas; Géraldine Picard; Virginie Desestret; François Ducray; Veronique Rogemond; Dimitri Psimaras; Jean-Christophe Antoine; Jean-Yves Delattre; Laurent Groc; Marion Leboyer; Jerome Honnorat
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-08-29

10.  Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients.

Authors:  Julia Herken; Harald Prüss
Journal:  Front Psychiatry       Date:  2017-02-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.